High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade-Reference-Cited by-同舟云学术

High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade

Published:2020-09 Issue:1 Volume:108 Page:70-80
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chua Kevin L.M.,Fehlings Michael,Yeo Eugenia L.L.,Nardin Alessandra,Sumatoh Hermi,Chu Pek Lim,Nei Wen-long,Ong Enya H.W.,Woo Wai Yee,Low Kar Perng,Wang Haitao,Poon Dennis J.J.,Liang Zhong-guo,Yao Kai,Huang Luo,Toh Chee Keong,Ang Mei-Kim,Farid Mohamad,Cheng Xin Min,Kanesvaran Ravindran,Dent Rebecca,Wee Joseph T.S.,Lim Tony K.H.,Iyer N. Gopalakrishna,Tan Daniel S.W.,Soo Khee Chee,Newell Evan W.,Chua Melvin L.K.

Funder

National Medical Research Council (NMRC) Clinician Scientist Award

National Research Foundation (NRF) Competitive Research Program, Singapore

Duke-NUS Oncology Academic Program Proton Research Program

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Radiotherapy induces responses of lung cancer to CTLA-4 blockade;Formenti;Nat Med,2018

2. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: A secondary analysis of the KEYNOTE-001 phase 1 trial;Shaverdian;Lancet Oncol,2017

3. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody;Dewan;Clin Cancer Res,2009